Gossamer Bio Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. ACN
9. USO
10. NVDA

Go back to Gossamer Bio Announces Fourth Quarter and Full-Year 2021 Financial Results and Provides Business Update

Gossamer Bio Inc. (GOSS) Reports In-Line Q4 EPS

March 3, 2022 4:04 PM EST

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q4 EPS of ($0.74), in-line with the analyst estimate of ($0.74).

Cash, cash equivalents and marketable securities as of December 31, 2021, were $325.2 million. As a result, we currently expect cash, cash equivalents and marketable securities, and access to our... More